A mouse model of Clostridium difficile-associated disease

Area of Science:

• Microbiology
• Infectious Diseases
• Animal Models

Background:

• Clostridium difficile infection causes significant healthcare-associated diarrhea and colitis.
• Current hamster models have limitations due to lack of specific reagents and disease severity.
• There is a need for a more human-relevant model to study Clostridium difficile-associated disease (CDAD).

Purpose of the Study:

• To establish a novel mouse model of antibiotic-induced CDAD.
• To create a model that more accurately reflects human CDAD pathogenesis and clinical presentation.
• To provide a valuable tool for evaluating new therapeutic strategies for CDAD.

Main Methods:

• C57BL/6 mice received a 3-day course of a broad-spectrum antibiotic cocktail.
• Mice were subsequently treated with clindamycin and then challenged with varying doses of Clostridium difficile.
• Disease progression and outcomes were monitored, including clinical signs and histological analysis.

Main Results:

• Antibiotic-treated mice challenged with C. difficile exhibited diarrhea and weight loss, with severity correlating to the challenge dose.
• Histological examination confirmed features consistent with CDAD.
• While oral vancomycin was protective during treatment, a significant mortality rate from colitis occurred post-treatment discontinuation.
• Survivors of initial CDAD showed resistance to rechallenge, and different C. difficile strains displayed varying virulence in this model.

Conclusions:

• A reproducible mouse model for Clostridium difficile-associated disease (CDAD) has been successfully developed.
• This model closely mimics human CDAD, making it suitable for research.
• The model will be instrumental in advancing the study of CDAD pathogenesis, immunity, and the development of novel treatments.